BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21773738)

  • 1. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs.
    Remane D; Meyer MR; Wissenbach DK; Maurer HH
    Anal Bioanal Chem; 2011 Sep; 401(4):1341-52. PubMed ID: 21773738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach.
    Montenarh D; Hopf M; Maurer HH; Schmidt P; Ewald AH
    Anal Bioanal Chem; 2014 Jan; 406(3):803-18. PubMed ID: 24309624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full validation and application of an ultra high performance liquid chromatographic-tandem mass spectrometric procedure for target screening and quantification of 34 antidepressants in human blood plasma as part of a comprehensive multi-analyte approach.
    Remane D; Meyer MR; Wissenbach DK; Maurer HH
    Anal Bioanal Chem; 2011 Jun; 400(7):2093-107. PubMed ID: 21472361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS/MS.
    Eliassen E; Kristoffersen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():72-80. PubMed ID: 25264915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography- tandem mass spectrometry.
    Simonsen KW; Hermansson S; Steentoft A; Linnet K
    J Anal Toxicol; 2010; 34(6):332-41. PubMed ID: 20663286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a multi-analyte LC-MS/MS approach for quantification of neuroleptics in whole blood, plasma, and serum.
    Montenarh D; Hopf M; Maurer HH; Schmidt P; Ewald AH
    Drug Test Anal; 2016 Oct; 8(10):1080-1089. PubMed ID: 26607679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast gas chromatography-negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood.
    Gunnar T; Ariniemi K; Lillsunde P
    J Mass Spectrom; 2006 Jun; 41(6):741-54. PubMed ID: 16645997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction.
    Sofalvi S; Lavins ES; Kaspar CK; Michel HM; Mitchell-Mata CL; Huestis MA; Apollonio LG
    J Anal Toxicol; 2020 Oct; 44(7):708-717. PubMed ID: 32808043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
    Kratzsch C; Tenberken O; Peters FT; Weber AA; Kraemer T; Maurer HH
    J Mass Spectrom; 2004 Aug; 39(8):856-72. PubMed ID: 15329838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma.
    Marin SJ; Roberts M; Wood M; McMillin GA
    J Anal Toxicol; 2012 Sep; 36(7):472-6. PubMed ID: 22833647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and quantitative screening method for 43 benzodiazepines and their metabolites, zolpidem and zopiclone in human plasma by liquid chromatography/mass spectrometry with a small particle column.
    Ishida T; Kudo K; Hayashida M; Ikeda N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2652-7. PubMed ID: 19501029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
    Bjørk MK; Nielsen MK; Markussen LØ; Klinke HB; Linnet K
    Anal Bioanal Chem; 2010 Apr; 396(7):2393-401. PubMed ID: 19921510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an SPE method for the determination of zaleplon and zopiclone in hemolyzed blood using fast GC with negative-ion chemical ionization MS.
    Karlonas N; Ramanavicius A; Ramanaviciene A
    J Sep Sci; 2014 Mar; 37(5):551-7. PubMed ID: 24375936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma.
    Mistri HN; Jangid AG; Pudage A; Shrivastav P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):137-48. PubMed ID: 18313371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fast liquid chromatography-tandem mass spectrometry method for determining benzodiazepines and analogues in urine. Validation and application to real cases of forensic interest.
    Salomone A; Gerace E; Brizio P; Gennaro MC; Vincenti M
    J Pharm Biomed Anal; 2011 Nov; 56(3):582-91. PubMed ID: 21737221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair.
    Laloup M; Ramirez Fernandez Mdel M; De Boeck G; Wood M; Maes V; Samyn N
    J Anal Toxicol; 2005 Oct; 29(7):616-26. PubMed ID: 16419390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization.
    Remane D; Meyer MR; Wissenbach DK; Maurer HH
    Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3103-8. PubMed ID: 20941756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS/MS.
    Vårdal L; Wong G; Øiestad ÅML; Pedersen-Bjergaard S; Gjelstad A; Øiestad EL
    Anal Bioanal Chem; 2018 Aug; 410(20):4967-4978. PubMed ID: 29947895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a fast ionic liquid-based dispersive liquid-liquid microextraction procedure combined with LC-MS/MS analysis for the quantification of benzodiazepines and benzodiazepine-like hypnotics in whole blood.
    De Boeck M; Missotten S; Dehaen W; Tytgat J; Cuypers E
    Forensic Sci Int; 2017 May; 274():44-54. PubMed ID: 28094153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a UHPLC MS/MS-based multianalyte approach for screening and validated quantification of drugs in human blood plasma often requested in the context of brain death diagnosis.
    Remane D; Montenarh D; Meyer MR; Maurer HH
    Ther Drug Monit; 2014 Apr; 36(2):257-60. PubMed ID: 24232124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.